Nucliq Biologics
Nucliq Biologics is a health tech company founded in 2019 in St. John's, Newfoundland and Labrador, focused on transforming health management starting with the gut microbiome. They leverage AI, multi-omics science, and microbiome expertise to develop personalized, data-driven solutions and precision therapeutics targeting complex, chronic diseases through gut-derived drug candidates and microbial engineering. Their proprietary platform, Microterra AI, decodes microbial ecosystems to identify therapeutic targets and supports drug discovery and personalized health strategies, especially for hormone-linked conditions in women. The company collaborates with healthcare professionals and researchers across Canada and India, backed by government and global partnerships, advancing microbiome-based health innovations.
Nucliq Biologics
Nucliq Biologics is a health tech company founded in 2019 in St. John's, Newfoundland and Labrador, focused on transforming health management starting with the gut microbiome. They leverage AI, multi-omics science, and microbiome expertise to develop personalized, data-driven solutions and precision therapeutics targeting complex, chronic diseases through gut-derived drug candidates and microbial engineering. Their proprietary platform, Microterra AI, decodes microbial ecosystems to identify therapeutic targets and supports drug discovery and personalized health strategies, especially for hormone-linked conditions in women. The company collaborates with healthcare professionals and researchers across Canada and India, backed by government and global partnerships, advancing microbiome-based health innovations.